Literature DB >> 1244907

Hybrid erythrocytes for membrane studies in sickle cell disease.

M R Clark, S B Shohet.   

Abstract

A hybrid erythrocyte model for membrane studies in sickle cell disease has been developed. The model consists of normal red cell membranes containing hemoglobin S and sickle cell membranes containing hemoglobin A. In hybrids, complete hemoglobin exchange has been achieved together with restoration of low membrane permeability to potassium. Normal membranes containing HbS sickle upon deoxygenation and assume the characteristic appearance of irreversibly sickled cells (ISC) after prolonged anoxia. It is suggested that the hybrid model will be useful in defining further the process of ISC formation and in studying the influence of sickle hemoglobin upon the function of the surrounding membrane.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1244907

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Gel electrophoresis of the human erythrocyte membrane proteins: aberrant patterns in hematological and non-hematological diseases.

Authors:  V Anselstetter
Journal:  Blut       Date:  1978-03-15

2.  Deformability of oxygenated irreversibly sickled cells.

Authors:  M R Clark; N Mohandas; S B Shohet
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

3.  Deformation of transforming red cells in various pH solutions.

Authors:  T Nagasawa
Journal:  Experientia       Date:  1981

4.  Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. I. Biochemical identification of rearrangements in the spectrin/actin binding domain and functional characterizations.

Authors:  S L Marchesi; J Conboy; P Agre; J T Letsinger; V T Marchesi; D W Speicher; N Mohandas
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

5.  Reconstitution of spectrin-deficient, spherocytic mouse erythrocyte membranes.

Authors:  S B Shohet
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

6.  Oligopeptides as potential antiaggregation agents for deoxyhemoglobin S.

Authors:  S Kubota; J T Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Restoration of normal membrane stability to unstable protein 4.1-deficient erythrocyte membranes by incorporation of purified protein 4.1.

Authors:  Y Takakuwa; G Tchernia; M Rossi; M Benabadji; N Mohandas
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.